top of page

Vefron

ACTIVE INGREDIENT

Ondansetron Hydrochloride

INDICATIONS

  • Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy or radiotherapy.

  • Prevention of postoperative nausea and/or vomiting.

vefron_box_en.png

FORMS

  • fc. tab 8 mg x 15

  • inj sol 8 mg/4 ml-vial x 1

User Guide

Για Επαγγελματίες

T.: 210 9423677   info@opusmateria.gr

bottom of page